ASAM Provider Guide

National Practice Guideline

ASAM Opioid Addiction Treatment GUIDELINES Apps and Pocket Guides brought to you courtesy of Guideline Central. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1019954

Contents of this Issue

Navigation

Page 22 of 23

Antagonist Rx Rx Adjustments Setting Notes Naltrexone should not be initiated May be discontinued if risk of relapse is low Continue only with consent Dose increase as pregnancy advances Level 4 for methadone induction and buprenorphine Rx Encourage breast feeding Naltrexone XR or oral Mild: NSAIDs or acetaminophen Moderate: Increase agonist or add opioid Severe: Discontinue buprenorphine; add a high potency opioid (fentanyl) All Discontinue oral naltrexone 72 hrs (or 30 days for extended-release) before surgery Naltrexone XR or oral N/A All Legal requirements and FDA approvals for under age 18 Naltrexone XR or oral Manage drug interactions Consider Levels 1 or 2 for coincident schizophrenia Naltrexone XR Prison or parolee Levels 1–4 Initiate Rx ≥30 days before release 21

Articles in this issue

Archives of this issue

view archives of ASAM Provider Guide - National Practice Guideline